These multinational giants offer the stability of international markets whilst capturing Brazil's economic potential. It's a smart way to benefit from Brazilian growth through established global companies.
By investing in US and EU-listed shares, you can potentially hedge against Brazilian real fluctuations whilst maintaining exposure to the country's economic development.
These blue-chip companies are built for long-term wealth creation. Their deep Brazilian connections mean you're positioned to benefit as the country's economy continues to develop.
Market capitalization breakdown for the provided basket of Brazilian and related global equities.
VALE: $50.91B
ITUB: $72.29B
ABEV: $34.50B
This basket offers a strategic approach to Brazilian investment through established multinational corporations. Rather than direct exposure to local markets, it focuses on global blue-chip companies that are deeply integrated into Brazil's consumer, industrial, and agricultural sectors, providing a unique form of diversification.
These are US and EU-listed shares of global corporations with significant Brazilian operations. This approach uses established international market infrastructure whilst offering exposure to Brazil's growth trajectory through robust, globally-listed enterprises that serve Brazil's large domestic market.
Each company was selected for its significant revenue streams, supply chains, or infrastructure in Brazil. The selection includes global consumer giants, industrial leaders supplying critical technology, and major players in the agribusiness value chain connecting Brazilian output to global consumers.
For Brazilians, investing in global companies with strong local operations may offer a way to manage domestic economic risks and currency fluctuations. This basket provides exposure to leading US and EU-listed blue-chip corporations that are deeply integrated into the Brazilian economy.
์ด ๋ฐ์ค์ผ์ ์ ์ฒด ์คํ ๋ฆฌ๋ฅผ ํ์ธํ์ธ์. ๋ฆฌ์คํฌ์ ์ ์ฌ๋ ฅ์ ๋ค๋ฃฌ ์์ธ ๊ธฐ์ฌ๋ฅผ ์ฝ์ด๋ณด์ธ์.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
10์ 8 ๊ฒ์
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
+5
Here are a few of the assets in this group. Create an account to unlock the full list.
์ด ๊ทธ๋ฃน์ ์์ฐ 15๊ฐ ์ค 13๊ฐ๊ฐ ์ ๋ฌธ ์ ๋๋ฆฌ์คํธ๋ก๋ถํฐ ๋งค์ ์๊ฒฌ์ ๋ฐ์์ต๋๋ค.
